COLLAPSE
Cost of healthcare has continued to rise over the years in the United States. The 21st century healthcare policy makers are left with the burden of figuring out the best way to cut down the high prize and at the same time be able to provide quality care, and affordable access to care for all Americans without compromising the ethical values of the people. The medical cost-benefit of the prostate cancer drug, provenge, is one of those issues that are under consideration: Debate is going on, on, the ethical and economic challenges related to policy decisions on whether to fund this drug that is estimated to cost about $93,000.00 per treatment for one person, or not to fund it (Stein, 2010) . This is a tough decision to make whichever way one tries to view it.…